Milind Nadkar

1.1k total citations
58 papers, 660 citations indexed

About

Milind Nadkar is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Milind Nadkar has authored 58 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Rheumatology, 16 papers in Immunology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Milind Nadkar's work include Systemic Lupus Erythematosus Research (16 papers), Atherosclerosis and Cardiovascular Diseases (6 papers) and Peripheral Neuropathies and Disorders (4 papers). Milind Nadkar is often cited by papers focused on Systemic Lupus Erythematosus Research (16 papers), Atherosclerosis and Cardiovascular Diseases (6 papers) and Peripheral Neuropathies and Disorders (4 papers). Milind Nadkar collaborates with scholars based in India, United States and France. Milind Nadkar's co-authors include Vandana Pradhan, Kanjaksha Ghosh, Anjali Rajadhyaksha, Anita Nadkarni, Manisha Patwardhan, Rohini Samant, Srini V. Kaveri, Manisha Madkaikar, Jagadeesh Bayry and M Jadhav and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medical Virology and Cytokine.

In The Last Decade

Milind Nadkar

54 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Milind Nadkar India 14 197 151 104 90 83 58 660
Bernard Ng United States 11 231 1.2× 133 0.9× 113 1.1× 108 1.2× 71 0.9× 28 776
Hye Won Kim South Korea 18 169 0.9× 150 1.0× 69 0.7× 159 1.8× 134 1.6× 72 820
Cláudia Diniz Lopes Marques Brazil 19 239 1.2× 211 1.4× 138 1.3× 155 1.7× 109 1.3× 53 886
Joaquín Borrás‐Blasco Spain 15 156 0.8× 172 1.1× 55 0.5× 36 0.4× 110 1.3× 61 618
David Gordon United States 16 239 1.2× 232 1.5× 121 1.2× 158 1.8× 69 0.8× 33 726
José Luis Aguilar United States 15 184 0.9× 124 0.8× 48 0.5× 140 1.6× 160 1.9× 46 1.0k
P B Rylance United Kingdom 18 120 0.6× 158 1.0× 56 0.5× 174 1.9× 95 1.1× 31 904
Franz Ratzinger Austria 14 74 0.4× 148 1.0× 73 0.7× 71 0.8× 170 2.0× 41 583
Jennifer Seifert United States 20 170 0.9× 134 0.9× 74 0.7× 224 2.5× 139 1.7× 44 1.3k
Andréa Tavares Dantas Brazil 20 273 1.4× 354 2.3× 112 1.1× 169 1.9× 128 1.5× 48 1.0k

Countries citing papers authored by Milind Nadkar

Since Specialization
Citations

This map shows the geographic impact of Milind Nadkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milind Nadkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milind Nadkar more than expected).

Fields of papers citing papers by Milind Nadkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milind Nadkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milind Nadkar. The network helps show where Milind Nadkar may publish in the future.

Co-authorship network of co-authors of Milind Nadkar

This figure shows the co-authorship network connecting the top 25 collaborators of Milind Nadkar. A scholar is included among the top collaborators of Milind Nadkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milind Nadkar. Milind Nadkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pradhan, Vandana, et al.. (2025). Deciphering the lectin pathway among Systemic Lupus Erythematosus (SLE) patients from Western India. Immunobiology. 230(4). 152937–152937.
2.
Khopkar, Uday, Milind Nadkar, Anjali Rajadhyaksha, et al.. (2023). A comparative study of modulatory interaction between cytokines and apoptotic proteins among Scleroderma patients with and without pulmonary involvement. Cytokine. 166. 156183–156183. 2 indexed citations
3.
Kerkar, Prafulla, et al.. (2021). A longitudinal study of antibody responses to selected host antigens in rheumatic fever and rheumatic heart disease. Journal of Medical Microbiology. 70(5). 4 indexed citations
4.
Kumar, Suresh, Rosemarie de Souza, Milind Nadkar, et al.. (2021). A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19. Expert Opinion on Biological Therapy. 21(5). 675–686. 22 indexed citations
5.
Pradhan, Vandana, et al.. (2020). Role of Mmp-2 and Its Inhibitor Timp-2 As Biomarkers for Susceptibility to Systemic Lupus Erythematosus. Biomarkers in Medicine. 14(12). 1109–1119. 7 indexed citations
6.
Kerkar, Prafulla, et al.. (2020). Association of PON1 Gene Polymorphisms and Enzymatic Activity With Risk of Coronary Artery Disease. Future Cardiology. 17(1). 119–126. 13 indexed citations
7.
Arya, Dharamvir Singh, Subhankar Chowdhury, Rajeev Chawla, et al.. (2019). Clinical Benefits of Fixed Dose Combinations Translated to Improved Patient Compliance.. PubMed. 67(12). 58–64. 10 indexed citations
8.
Pradhan, Vandana, et al.. (2018). Association of Human Leucocyte Antigen (HLA) class II with systemic lupus erythematosis (SLE) patients from western India. Meta Gene. 16. 230–233. 5 indexed citations
9.
Pradhan, Vandana, Maxime Lecerf, Anjali Rajadhyaksha, et al.. (2018). Catalytic antibodies in patients with systemic lupus erythematosus. European Journal of Rheumatology. 5(3). 173–178. 7 indexed citations
10.
Nadkar, Milind, et al.. (2018). Adipokine interactions promote the pathogenesis of systemic lupus erythematosus. Cytokine. 111. 20–27. 33 indexed citations
11.
Dhamija, Puneet, Sanjay Kalra, Pramod Kumar Sharma, et al.. (2017). Indian College of Physicians (ICP) Position Statement on Pharmacovigilance.. PubMed. 65(3). 63–66. 4 indexed citations
12.
Kakati, Sanjeeb, Lahari Saikia, Anjali Rajadhyaksha, et al.. (2017). A Comparitive Study of Anticardiolipin Antibodies among Systemic Lupus Erythematosus Patients from Western and Eastern India.. PubMed. 65(3). 14–19. 1 indexed citations
13.
Nadkar, Milind, Anjali Rajadhyaksha, Manisha Patwardhan, et al.. (2017). Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein‐Barr virus antibody profile. Journal of Medical Virology. 90(3). 559–563. 29 indexed citations
14.
Nadkar, Milind. (2017). Executive Summary: Association of Physicians of India: Position Statement on Role of Chirally Pure Molecules in Clinical Practice.. PubMed. 65(9). 60–63.
15.
Nadkarni, Anita, et al.. (2016). Do high sensitivity C-reactive protein and serum interleukin-6 levels correlate with disease activity in systemic lupus erythematosuspatients?. Journal of Postgraduate Medicine. 63(2). 92–95. 22 indexed citations
16.
Nadkar, Milind, et al.. (2015). Guillain Barré Syndrome, Systemic Lupus Erythematosus and Acute Intermittent Porphyria – A Deadly Trio.. PubMed. 63(11). 60–3. 7 indexed citations
17.
Pradhan, Vandana, Milind Nadkar, Anjali Rajadhyaksha, et al.. (2014). Effect of Proinflammatory Cytokines (IL-6, TNF-α, and IL-1β) on Clinical Manifestations in Indian SLE Patients. Mediators of Inflammation. 2014. 1–8. 123 indexed citations
18.
19.
Nadkar, Milind, et al.. (2010). Migraine: pitfalls in the diagnosis.. PubMed. 58 Suppl. 10–3. 1 indexed citations
20.
Roshan, Sina Attar, et al.. (1996). Acute inflammatory demyelinating polyradiculo--neuropathy following anti rabies vaccine.. PubMed. 44(2). 141–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernard Ng Breakdown of academic impact, for papers by Hye Won Kim Breakdown of academic impact, for papers by Cláudia Diniz Lopes Marques Breakdown of academic impact, for papers by Joaquín Borrás‐Blasco Breakdown of academic impact, for papers by David Gordon Breakdown of academic impact, for papers by José Luis Aguilar Breakdown of academic impact, for papers by P B Rylance Breakdown of academic impact, for papers by Franz Ratzinger Breakdown of academic impact, for papers by Jennifer Seifert Breakdown of academic impact, for papers by Andréa Tavares Dantas
Rankless by CCL
2026